Zelenectide Pevedotin, BT8009, PEMBROLIZUMAB, AVELUMAB, CISPLATIN, CARBOPLATIN, GEMCITABINE
BT8009-230
Phase 3 small_molecule active
Quick answer
Zelenectide Pevedotin, BT8009, PEMBROLIZUMAB, AVELUMAB, CISPLATIN, CARBOPLATIN, GEMCITABINE for Locally advanced or metastatic urothelial cancer is a Phase 3 program (small_molecule) at BICYCLE THERAPEUTICS with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BICYCLE THERAPEUTICS
- Indication
- Locally advanced or metastatic urothelial cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active